Lymphocyte Function-Associated Antigen-1 Antagonists [MoA] - N0000192700

Pharmacologic Class Information

Pharmacologic Code N0000192700
Pharmacologic Name Lymphocyte Function-Associated Antigen-1 Antagonists
Pharmacologic Uses
  • lymphocyte function-associated antigen-1 (LFA-1) antagonist
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Lymphocyte Function-Associated Antigen-1 Antagonists

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Lymphocyte Function-Associated Antigen-1 Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0911Xiidra Non-Proprietary Name: LifitegrastSolution/ DropsOphthalmicNovartis Pharmaceuticals CorporationACTIVE
54092-606Xiidra Non-Proprietary Name: LifitegrastSolution/ DropsOphthalmicTakeda Pharmaceuticals America, Inc.ACTIVE